Compositions and methods for inhibiting inflammation of vessel wall and/or formation of neointimal hyperplasia by gene therapy using a soluble Flt-1 (sFlt-1) gene, are provided. VEGF has an essential role in the development of neointimal hyperplasia by causing inflammation. sFlt-1 gene transfer to the site of vascular injury blocks Flt-1-mediated VEGF signal transduction, thereby inhibiting early inflammation as well as late neointimal hyperplasia. The present invention is useful for inhibiting or treating inflammation of vessel wall and/or formation of neointimal hyperplasia in a patient with risk of post coronary intervention restenosis, atherosclerosis, arteriosclerosis, or edema.

 
Web www.patentalert.com

< Inducible plasmid vector encoding tgf-beta and use thereof

< Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries

> Calpains as targets for inhibition of prion propagation

> Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses

~ 00296